MHRA Publishes Annual Report

The Medicines and Healthcare products Regulatory Agency (MHRA) annual report and accounts 2016 to 2017 have been published. The annual report and accounts give a selective overview of the events that have had most impact on the agency during the past year and the work undertaken to deliver on the agency’s 5-year corporate plan.

Key acheivements include the MHRA’s involvement in early access programs such as the Early Access to Medicines Scheme (EAMS) as well as European wide schemes such as PRIME.

It has also contributed to the Accelerated Access Review, and wishes to take the recommendations forward.

See the annual report here.

Tagged with

Published 21. July 2017 in News UK